Carisma Therapeutics Stock Forecast - Accumulation Distribution
| CARM Stock | 0.85 0.01 1.19% |
Carisma Stock Forecast is based on your current time horizon. Although Carisma Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Carisma Therapeutics' systematic risk associated with finding meaningful patterns of Carisma Therapeutics fundamentals over time.
Carisma |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 5163.98 | 9818.14 |
| Check Carisma Therapeutics Volatility | Backtest Carisma Therapeutics | Trend Details |
Carisma Therapeutics Trading Date Momentum
| On October 01 2024 Carisma Therapeutics was traded for 0.95 at the closing time. The top price for the day was 1.02 and the lowest listed price was 0.95 . The trading volume for the day was 139.4 K. The trading history from October 1, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.06% . The overall trading delta against the current closing price is 4.08% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Carisma Therapeutics to competition |
Other Forecasting Options for Carisma Therapeutics
For every potential investor in Carisma, whether a beginner or expert, Carisma Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Carisma Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Carisma. Basic forecasting techniques help filter out the noise by identifying Carisma Therapeutics' price trends.Carisma Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Carisma Therapeutics stock to make a market-neutral strategy. Peer analysis of Carisma Therapeutics could also be used in its relative valuation, which is a method of valuing Carisma Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Carisma Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Carisma Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Carisma Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Carisma Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Carisma Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Carisma Therapeutics shares will generate the highest return on investment. By undertsting and applying Carisma Therapeutics stock market strength indicators, traders can identify Carisma Therapeutics entry and exit signals to maximize returns.
Carisma Therapeutics Risk Indicators
The analysis of Carisma Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Carisma Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting carisma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.15 | |||
| Standard Deviation | 2.91 | |||
| Variance | 8.46 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Carisma Therapeutics to cross-verify your projections. To learn how to invest in Carisma Stock, please use our How to Invest in Carisma Therapeutics guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Carisma Therapeutics. If investors know Carisma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Carisma Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 0.493 | Quarterly Revenue Growth (0.12) | Return On Assets (0.56) | Return On Equity (3.63) |
The market value of Carisma Therapeutics is measured differently than its book value, which is the value of Carisma that is recorded on the company's balance sheet. Investors also form their own opinion of Carisma Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Carisma Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Carisma Therapeutics' market value can be influenced by many factors that don't directly affect Carisma Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Carisma Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Carisma Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Carisma Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.